Gainersπ & Losersπ
Our Biggest Gainers & Losers of the Day in the $100,000 Build Portfolio
For the 5th December 2024:
A Real-Life Crime Drama π¬π«
Profit from Oil & Gas π’ π₯

A Real-Life Crime Drama π¬π«
Money & murder come together a little too often. UnitedHealthβs CEO, Brian Thompson, was tragically killed in Manhattan on Wednesday.
Itβs looking like a targeted attack & the details are straight out of a movie. Shell casings engraved with cryptic words like βdeny,β βdepose,β βdefend.β which might be referencing a 2010 book bashing the insurance industry.
UnitedHealthβs insurance division has been getting some backlash over denied claims. Itβs allegedly down to ruthlessly using AI for decision-making. Best guesses are that probably has something to do with the shooting.

UNH in the red after the terrible news
As you might expect, the market didnβt love this news & UNH is down over 5% on the day.
Is it worth buying the bad news? Or is the drop justified?
The Numbers Look Good π
If we take a look back at UNHβs latest earnings report, everything looks good.
π΅ Revenue: $101 billion in Q3 (+9% YoY).
π Big moves: Optum Health & Optum Rx added $7 billion to the top line.
π Big Growth goals: Aiming for 13-16% annual EPS growth.

Latest earnings report for UNH
All pretty healthy & thereβs no signs of slowing down yet. Their core business operations are firing on all cylinders, too.
Theyβre making a focus on better outcomes and lower costs with value based care. AI could be the way forward by doing stuff like:
Shortening pharmacy turnaround times from 7.5 days to 29 seconds.
Making clinicians more efficient by automating patient reviews.
Saving $1B in operational efficiencies over two years.
Weβd all benefit in a world where healthcare is smarter, faster & cheaper. These types of innovation are getting us closer to that world.
Resilience Thatβs Built Different π‘οΈ
So the business is doing fine. Great. But your CEO being murdered after an investor conference is definitely a black Swan event which makes it tough to figure out where the stock goes from here.
I do think that theyβll be fine long term. Why? Theyβve dealt with some pretty big issues in the past & come out just fine. (Granted nothing quite like this weekβs event).
Iβm talking about the medicare rate cuts. They were handled in their stride. Cyberattacks? Survived. Inflation? Still posting big numbers.
Just to be super clear. Iβm not saying the CEO being murdered is just another day at the office. Itβs a super sad & tragic event. Iβm just saying that I think theyβll be able to navigate through it & any huge draw down is a buying opportunity.
The Plan? πΊ
The cause of the drop naturally makes the stock a little more unpredictable than usual.
At market close a further push down was rejected. If that sentiment stays for market open tomorrow, Iβll be adding a small amount to my position size.

A long tail on the last candle of the day where price was rejected might be a good sign
If the fall continues, Iβll be keeping my eyes out for $555 which has been a support level since July.
My first price target will be somewhere around $620 which is recent highs & would be an 11%ish gain from current price.
UnitedHealth is the perfect mix of tech & solid execution. When youβve got a healthcare giant turning $101 billion quarters into a regular thing, itβs hard to imagine they donβt reclaim old highs as a minimum.

Profit from Oil & Gas π’ π₯
Is oil and gas missing from your portfolio?
With Klondike Royalties, you could gain from established oil and gas assets. Each royalty offers potential returns from real production, managed by deeply experienced operators. Add a piece of the energy sector to your portfolio.

What did you think of today's update?
Thatβs all! See you same time tomorrow π
P.S Hit reply & let me know what you thought of todayβs newsletter. All feedback is welcomed β€οΈ


